Table 1.
Characteristic | Pediatric patients3–5,7 | Adult patients4,6,7 |
---|---|---|
Incidence | Approximately 15 200/y in United States | Approximately 292 000/y in United States |
Age | Median: 1–2 y; mean: 3–5 ya | Mean: 66 y |
Male sex | 50%−55% | 60% |
Hospital location | 85%−90% In monitored settingsb | 50% In monitored settingsb |
Airway in place | Approximately 80% | Approximately 30%−35% |
Cause of cardiac arrest | Most with respiratory failure and/or progressive shock | 50%−60% Cardiac; 15%−40% respiratory |
Initial cardiac arrest rhythm | 50% Bradycardia with poor perfusion; 40% other nonshockable rhythms | 80% Nonshockable rhythms (pulseless electrical activity or asystole) |
Survivalto discharge | 45%−50% (40%Among those with pulseless events) | 25% |
Neurological outcome | Favorable in 80%−90% of survivorsc | Good functional status in 80% of survivorsd |
Age depends on inclusion criteria of studies.
Monitored settings include intensive care units, emergency departments, and operating rooms.
Pediatric Cerebral Performance Category scale (range: 1–6, with 1 indicating normal function and 6 indicating brain death8): 1 to 3 or unchanged from baseline.
Cerebral Performance Category scale: 1 or 2.